The estimated Net Worth of Peter J. Kuipers is at least $17.8 Milion dollars as of 26 August 2022. Mr. Kuipers owns over 15,500 units of Omnicell stock worth over $3,308,896 and over the last 9 years he sold OMCL stock worth over $11,570,505. In addition, he makes $2,924,710 as Chief Financial Officer a Executive Vice President at Omnicell.
Peter has made over 22 trades of the Omnicell stock since 2017, according to the Form 4 filled with the SEC. Most recently he exercised 15,500 units of OMCL stock worth $1,083,140 on 26 August 2022.
The largest trade he's ever made was selling 24,504 units of Omnicell stock on 11 March 2019 worth over $2,057,601. On average, Peter trades about 3,506 units every 36 days since 2015. As of 26 August 2022 he still owns at least 76,826 units of Omnicell stock.
You can see the complete history of Mr. Kuipers stock trades at the bottom of the page.
Peter J. Kuipers is Chief Financial Officer, Executive Vice President of Omnicell, Inc. Mr. Kuipers joined Omnicell in August 2015 as Executive Vice President and Chief Financial Officer. Prior to Omnicell, Mr. Kuipers served as Senior Vice President and Chief Financial Officer of Quantcast Corp., a global technology company that specializes in digital audience measurement and real-time advertising. From May 2013 to December 2014, Mr. Kuipers served as Executive Vice President and Chief Financial Officer of The Weather Company, a media and global technology leader operating The Weather Channel, weather.com, wunderground.com and its professional services division WSI. From September 2009 to April 2013, Mr. Kuipers served in various financial management positions at Yahoo! Inc., a global internet technology company, most recently as Vice President, Finance for the Americas region. Prior to Yahoo! Inc., Mr. Kuipers held financial leadership roles at Altera Corporation, General Electric Company, and Akzo Nobel. He started his career with Ernst & Young and worked in both the Netherlands and Seattle, Washington. Mr. Kuipers received a Master’s Degree in Economics and Business Administration from Maastricht University and is a Chartered Accountant in the Netherlands.
As the Chief Financial Officer a Executive Vice President of Omnicell, the total compensation of Peter Kuipers at Omnicell is $2,924,710. There are 1 executives at Omnicell getting paid more, with Randall Lipps having the highest compensation of $7,208,970.
Peter Kuipers is 48, he's been the Chief Financial Officer a Executive Vice President of Omnicell since 2015. There are 16 older and 3 younger executives at Omnicell. The oldest executive at Omnicell, Inc. is Sara White, 74, who is the Independent Director.
Peter's mailing address filed with the SEC is 590 E Middlefield Rd, Mountain View, CA 94043, USA.
Over the last 21 years, insiders at Omnicell have traded over $118,258,750 worth of Omnicell stock and bought 526,030 units worth $5,215,749 . The most active insiders traders include William H Jr Younger, Randall A Lipps a Benjamin A Horowitz. On average, Omnicell executives and independent directors trade stock every 10 days with the average trade being worth of $482,255. The most recent stock trade was executed by Christine Marie Mellon on 9 June 2023, trading 7,951 units of OMCL stock currently worth $581,536.
since 1992, omnicell has been creating new efficiencies to improve patient care, anywhere it is delivered. omnicell is a leading supplier of comprehensive automation and business analytics software for patient-centric medication and supply management across the entire health care continuum—from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. omnicell’s automated hardware/software systems for medication dispensing include solutions from the point of entry into the hospital through the central pharmacy, nursing unit, operating room, and patient bedside. our supply management systems promote greater cost control and charge capture for payer reimbursement, and improve management and reordering of inventory. omnicell® products range from high-security, closed-cabinet systems and software to open-shelf and combination systems in the nursing unit, cath lab, and operating room. more than 3,200 customers worldwide have utilized omnice
Omnicell executives and other stock owners filed with the SEC include: